View Post

NCCN Announces Expanded Practice Guidelines for Breast Cancer With Hereditary Risks

In In The News by Barbara Jacoby

By: Gillian McGovern From: .pharmacytimes.com Key Takeaways Expanded guidelines cover genetic/familial high-risk assessment for breast, ovarian, pancreatic, and prostate cancers, incorporating the latest research and expert recommendations. Guidelines detail when genetic testing is recommended, the type of testing, and management strategies for hereditary cancer risks, including screening and prevention. Emphasis is placed on genetic testing’s role in cancer care, enhancing …